At what pace is the typhoid antibody testing market growing, and what is its estimated value?
The typhoid antibody testing market size has grown strongly in recent years. It will grow from $7.83 billion in 2024 to $8.46 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to rising collaborative effort aimed at the development of new testing tools, rise in developing countries, increasing competition, cost effective diagnostic kits, and government support.
The typhoid antibody testing market size is expected to see strong growth in the next few years. It will grow to $11.44 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increasing prevalence of the disease, increasing rate of morbidity and mortality, travel-related testing, increasing healthcare spending, and growing awareness about typhoid fever among healthcare professionals and the public. Major trends in the forecast period include advanced technologies, global health initiatives, emphasis on outbreak preparedness and surveillance, growing work toward the development of novel typhoid antibody tests, and rise in healthcare spending.
Get Your Free Sample of The Global Typhoid Antibody Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16815&type=smp
What are the top drivers to the rising demand in the typhoid antibody testing market?
The rise in waterborne diseases is expected to propel the growth of the typhoid antibody testing market going forward. Waterborne diseases refer to illnesses caused by pathogenic microorganisms transmitted through contaminated water. The rise in waterborne diseases is due to poor sanitation and hygiene, lack of access to clean drinking water, rapid urbanization, climate change, and agricultural runoff. Typhoid antibody testing helps in the early diagnosis, confirmation, and monitoring of treatment efficacy of typhoid fever, aiding in the identification of carriers and implementation of preventive measures, playing a crucial role in managing and controlling waterborne diseases. For instance, according to the Coalition against Typhoid, a US-based organization dedicated to preventing typhoid and other invasive salmonellosis, from January to August 2022, the Philippines recorded 7,681 typhoid (a waterborne disease) cases, marking a 109% increase compared to the same period in the previous year. Therefore, the rise in waterborne diseases is driving the growth of the typhoid antibody testing market.
How is the typhoid antibody testing market segmented?
The typhoid antibody testing market covered in this report is segmented –
1) By Product Type: Rapid Serological Tests, Hem-agglutination And Co-agglutination, Counter Immunoelectrophoresis, Typhidot Test, Widal Test
2) By Paratyphi Type: Paratyphi A, Paratyphi B, Paratyphi C
3) By End-User: Hospitals, Serological Testing Centers, Clinics, Diagnostic Centers, Other End Users
Subsegments:
1) By Rapid Serological Tests: Lateral Flow Immunoassays (LFIA), Immunochromatographic Tests (ICT), Enzyme-Linked Immunosorbent Assays (ELISA)
2) By Hem-agglutination And Co-agglutination: Hemagglutination Assay, Co-agglutination Assay
3) By Counter Immunoelectrophoresis: Gel-Based Counter Immunoelectrophoresis, Paper-Based Counter Immunoelectrophoresis
4) By Typhidot Test: Typhidot-M (IgM) Test, Typhidot-G (IgG) Test
5) By Widal Test: Tube Widal Test, Slide Widal Test
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/typhoid-antibody-testing-global-market-report
Who are the top competitors in the typhoid antibody testing market?
Major companies operating in the typhoid antibody testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Meridian Bioscience Inc., Sekisui Diagnostics, CTK Biotech Inc., Creative Diagnostics, Fortress Diagnostics Ltd., CerTest Biotec S.L, InBios International Inc., J. Mitra & Co. Pvt. Ltd, The Native Antigen Company, AroCell, AccuBioTech Co. Ltd, Vanguard Diagnostics private limited., Atlas Medical, Suburban Diagnostics India Private Limited, Biorex Diagnostics, Genebio Healthcare Private Limited, ICT Diagnostics
What significant trends should we anticipate in the typhoid antibody testing market over the forecast period?
Major companies operating in the typhoid antibody testing market are focused on developing innovative products, such as molecular diagnostic tests, to enhance the accuracy and speed of typhoid fever diagnosis. Molecular diagnostic tests offer high sensitivity and specificity, allowing for accurate and rapid detection of pathogens like Salmonella Typhi in cases of typhoid fever. For instance, in April 2023, Vanguard Diagnostics, an India-based diagnostic reagent developer, launched the VANSCAN typhoid RT PCR test, a molecular diagnostic test using its patented technology. It is designed to detect and diagnose typhoid fever through a real-time PCR (RT-PCR) testing approach, which is more accurate and sensitive than traditional serological tests. The VANSCAN Typhoid RT PCR Test marks a significant advancement in typhoid diagnostics, establishing a new gold standard for early, accurate, and reliable disease detection in India and globally.
Which regional trends are influencing the typhoid antibody testing market, and which area dominates the industry?
Asia-Pacific was the largest region in the typhoid antibody testing market in 2023. The regions covered in the typhoid antibody testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Typhoid Antibody Testing Market Report 2025 Offer?
The typhoid antibody testing market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Typhoid antibody testing is a diagnostic procedure designed to detect antibodies against Salmonella enterica serotype Typhi, the bacterium responsible for causing typhoid fever. The primary aim of typhoid antibody testing is to diagnose typhoid fever by identifying the immune response (antibodies) to Salmonella Typhi. Typhoid antibody testing helps to provide timely and accurate diagnosis, enabling appropriate treatment and management of the disease.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16815
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
